<DOC>
	<DOCNO>NCT01847196</DOCNO>
	<brief_summary>The primary objective clinical trial obtain initial insight safety Angel® Catheter critically ill subject high risk venous thromboembolism ( VTE ) disease AND receive pharmacological thromboprophylaxis .</brief_summary>
	<brief_title>Angel® Catheter Early Feasibility Clinical Study</brief_title>
	<detailed_description>STUDY ENDPOINTS 1 . Primary Endpoints : . Initial Insights Safety - Success delivery , maintenance removal Angel® Catheter . - Incidence seriousness adverse event . - Incidence device procedure-related adverse event . 2 . Secondary Endpoints : - Evaluation separate combine function IVC filter central venous catheter device . - Evaluate investigative site 's ability comprehend procedural step ( Per Insertion Procedure , Repositioning Procedure , Removal Procedure ) - Evaluate operator challenge device use ( human factor ) . - Evaluate success challenge encounter conduct pivotal trial critically ill patient population - include limited Informed Consent enrollment . ENROLLMENT AND SUBJECT SAMPLE SIZE The study expect enroll 20 subject 4 US investigational site goal 10 evaluable subject Angel® Catheter placement attempt . STUDY DURATION The device design deploy less 30 day . After enrollment Angel® Catheter placement , subject follow daily post-removal , seven ( 7 ) day follow hospital discharge , whichever occur first .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>INCLUSION CRITERIA ( Must Answer YES Inclusion Criteria ) : 1 . Subject legally authorized representative willing able provide write informed consent , AND 2 . Subject 18 year old , AND 3 . Subject currently admit OR admit Intensive Care Unit ( ICU ) within ≤36 hour screen , AND 4 . Subject clinical need Central Venous Catheter , and/or subject exist Central Venous Catheter place &lt; 36 hour Angel® Catheter placement , AND 5 . Subject consider high risk PE meet ONE follow criterion : 1 . Subject multiple trauma least ONE following : Severe head injury Head injury long bone fracture Spinal cord injury paraplegia quadriplegia Multiple ( ≥2 ) long bone fracture Multiple ( ≥2 ) long bone fracture pelvic fracture Pelvic fracture require open fixation 2 . Critically ill subject Intensive Care Unit least ONE following : Hemorrhagic ischemic stroke Multiple organ failure Active recent bleeding ( within past 2 week ) Severe sepsis Lower extremity DVT Anticipated ventilator requirement great one week 3 . Critically ill subject require temporary ( ≥48 hour ) interruption medical thromboprophylaxis ( prophylactic anticoagulation ) EXCLUSION CRITERIA ( Must Answer NO All Exclusion Criteria ) : 1 . Subject pregnant lactating 2 . BMI = ( Weight ( lb ) x 703 ) / ( 〖Height〗^2 ( inch ) ) &gt; 45 ; BMI may also calculate http : //nhlbisupport.com/bmi/bminojs.htm 3 . Subject preexist IVC filter place 4 . Subject currently receive prophylactic anticoagulation , aspirin Plavix . Specifically , subject receive follow medication : heparin , low molecular weight heparin , factor Xa inhibitor ( i.e . xabans ) , Coumadin , thrombin inhibitor . 5 . Subject diagnosis pulmonary embolism 6 . Subject participate another clinical investigation 7 . Subject know hypersensitivity component Angel® Catheter , specifically Nitinol ( nickel and/or titanium ) 8 . Subject function pelvic renal allograft side available device insertion 9 . Subject undergone surgical procedure involve femoral vein pelvic vein device must insert 10 . Anatomic inability place Angel® Catheter ( include history thrombosis venous system side propose access ) 11 . Anticipated survival ≤48 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>PE</keyword>
	<keyword>DVT</keyword>
	<keyword>Deep Vein Thrombosis</keyword>
	<keyword>VTE</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>thromboprophylaxis</keyword>
	<keyword>contraindication thromboprophylaxis</keyword>
	<keyword>prophylactic</keyword>
	<keyword>prevention</keyword>
	<keyword>Inferior vena cava filter</keyword>
	<keyword>IVC filter</keyword>
	<keyword>filter</keyword>
	<keyword>prevention pulmonary embolism</keyword>
	<keyword>trauma</keyword>
	<keyword>critically-ill</keyword>
</DOC>